Insulin resistance and new insulins. 1977

D K Yue, and J R Turtle

Insulin therapy is required in the treatment of diabetic patients manifesting persistent ketosis. Although most patients in this category are young, many elderly diabetics fall into this group. In patients without ketosis, the indications for insulin therapy are less easy to define. In general, insulin is required if blood glucose levels cannot be maintained below 200mg/100ml following adequate diet, attainment of ideal body weight, and oral hypoglycaemic therapy.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias

Related Publications

D K Yue, and J R Turtle
December 1981, Annals of internal medicine,
D K Yue, and J R Turtle
February 2014, Diabetes technology & therapeutics,
D K Yue, and J R Turtle
February 2011, International journal of clinical practice. Supplement,
D K Yue, and J R Turtle
February 2013, Diabetes technology & therapeutics,
D K Yue, and J R Turtle
February 2012, International journal of clinical practice. Supplement,
D K Yue, and J R Turtle
February 2015, Diabetes technology & therapeutics,
D K Yue, and J R Turtle
September 1982, Irish medical journal,
D K Yue, and J R Turtle
June 2021, Diabetes technology & therapeutics,
D K Yue, and J R Turtle
March 2022, Diabetes technology & therapeutics,
D K Yue, and J R Turtle
February 2020, Diabetes technology & therapeutics,
Copied contents to your clipboard!